ACIU
Price:
$2.88
Market Cap:
$232.60M
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is ...[Read more]
Industry
Biotechnology
IPO Date
2016-09-23
Stock Exchange
NASDAQ
Ticker
ACIU
According to AC Immune S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.33. This represents a change of -17.12% compared to the average of 1.61 of the last 4 quarters.
The mean historical Current Ratio of AC Immune S.A. over the last ten years is 12.21. The current 1.33 Current Ratio has changed 990.77% with respect to the historical average. Over the past ten years (40 quarters), ACIU's Current Ratio was at its highest in in the September 2019 quarter at 22.08. The Current Ratio was at its lowest in in the June 2025 quarter at 1.33.
Average
12.21
Median
13.14
Minimum
1.71
Maximum
16.72
Discovering the peaks and valleys of AC Immune S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.72%
Maximum Annual Current Ratio = 16.72
Minimum Annual Increase = -81.50%
Minimum Annual Current Ratio = 1.71
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.71 | -81.50% |
| 2023 | 9.22 | -17.37% |
| 2022 | 11.16 | 10.26% |
| 2021 | 10.12 | -38.80% |
| 2020 | 16.53 | -1.12% |
| 2019 | 16.72 | 13.38% |
| 2018 | 14.75 | 11.05% |
| 2017 | 13.28 | -14.93% |
| 2016 | 15.61 | 20.04% |
| 2015 | 13.01 | 93.72% |
The current Current Ratio of AC Immune S.A. (ACIU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.36
5-year avg
9.75
10-year avg
12.21
AC Immune S.A.’s Current Ratio is less than Aldeyra Therapeutics, Inc. (2.86), less than Cellectis S.A. (1.38), less than Alto Neuroscience, Inc. (18.43), less than Silence Therapeutics plc (7.69), less than Amarin Corporation plc (3.45), less than Contineum Therapeutics, Inc. Class A Common Stock (29.07), less than Lyell Immunopharma, Inc. (7.65), less than Mereo BioPharma Group plc (8.13), less than Annexon, Inc. (5.67), less than Alpha Tau Medical Ltd. (8.43),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.86 | $293.49M | |
| 1.38 | $484.47M | |
| 18.43 | $415.67M | |
| 7.69 | $336.78M | |
| 3.45 | $340.44M | |
| 29.07 | $320.40M | |
| 7.65 | $540.20M | |
| 8.13 | $325.72M | |
| 5.67 | $536.98M | |
| 8.43 | $346.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is AC Immune S.A.'s Current Ratio?
How is the Current Ratio calculated for AC Immune S.A. (ACIU)?
What is the highest Current Ratio for AC Immune S.A. (ACIU)?
What is the 3-year average Current Ratio for AC Immune S.A. (ACIU)?
What is the 5-year average Current Ratio for AC Immune S.A. (ACIU)?
How does the current Current Ratio for AC Immune S.A. (ACIU) compare to its historical average?